Dr. Cohen is currently Associate Professor of Surgery and Pharmacology, Associate Chair in the Department of Surgery for Innovation and Entrepreneurship, Director of the Medical School Pathway of Excellence in Innovation and Entrepreneurship, Director of Endocrine Surgery Research, and a Principal Investigator in the Translational Oncology Program at the University of Michigan Rogel Cancer Center.
He received his bachelors in Chemical Engineering and his Medical Doctorate degrees from Washington University in St. Louis and completed his general surgery residency as well as a NIH-sponsored fellowship in endocrine and oncologic surgery at Barnes-Jewish Hospital. Before coming to the University of Michigan in 2012, he was Associate Professor of Surgery and Pharmacology and Vice-Chair for Research in the Department of Surgery at the University of Kansas.
In his roles as Associate Chair in Surgery and Path Director at the Medical School for Innovation and Entrepreneurship, he has put together along with the Fast Forward Medical Innovation group several educational programs in Innovation and Entrepreneurial Development (the only one of their kind in the world) for medical students, residents, and faculty as well as co-founding 3 start-up companies in the therapeutics drug and device industry designed to improve treatments and outcomes in cancer patients.
He has written and published over 70 original articles, 9 book chapters, and his research has been externally funded by the Susan G. Komen Foundation, the American Cancer Society, and the National Institute of Health as well as gifts from grateful patient donors. He has served on Grant Study Sections for the National Science Foundation and the Susan G. Komen Foundation, as well as on the Executive Council of the Association for Academic Surgery and the American Association for Endocrine Surgeons as the National Program Chair in 2013.
Clinical Specialization: His clinical interests and national expertise are in the areas of Endocrine Surgery: specifically thyroid surgery for benign and malignant disease, minimally invasive parathyroid surgery, and adrenal surgery, as well as Advanced Melanoma Surgery including hyperthermic isolated limb perfusion, a program he began here at Michigan in 2013 and is now one of the largest in the nation. He is Boarded by the American Board of Surgery and is a Fellow of the American College of Surgeons.
